Abstract: A cat toy includes a hollow structure and a clump of material disposed within the hollow structure. The clump of material includes cat attractant material. The hollow structure has at least one opening configured to release an aroma of the cat attractant material outside of the hollow structure and to maintain the clump of material entrapped within the hollow structure.

Abstract: A cat toy includes a hollow structure and a clump of material disposed within the hollow structure. The clump of material includes cat attractant material. The hollow structure has at least one opening configured to release an aroma of the cat attractant material outside of the hollow structure and to maintain the clump of material entrapped within the hollow structure.

Abstract: A pet toy apparatus that includes a suction cup, a support apparatus and a toy apparatus that are configured to be selectively coupled to one another to form a structure which can be hung from a supporting surface such as a window pane, a wall, etc. to attract a pet into play. The suction cup is configured to maintain the support apparatus at an angle with respect to a horizontal plane in order to increase the strength of the selective connection between the suction cup and the support apparatus.

Abstract: A stuffed toy includes a body and a head connected to the body, the body and the head together defining an internal space and forming an exterior of the stuffed toy. The stuffed toy includes a container at least partially filled with a cat attractant material which emits an aroma. The container is disposed within the internal space of the stuffed toy and has an opening in a portion of the internal space corresponding to the head such that the emitted aroma is greater at the head of the stuffed toy as compared to along the body.

Abstract: An applicator assembly, a method of assembly of the applicator and a method of use of the applicator. The applicator assembly includes a reservoir body, a neck that extends from the reservoir body and includes an exposable opening at a distal end thereof and a shroud that extends from the distal end about the exposable opening and a cap that is integrally formed with and releasably fixed to the distal end of the neck, fully encompassing the opening in the neck and sealing the reservoir body.

Abstract: The invention provides an ectoparasiticidal formulation which comprises an ectoparasiticidal agent, preferably the pyrethroid permethrin, as the pesticidally-active ingredient, together with a crystallization inhibitor selected from the group consisting of alkyl-substituted pyrrolidones, and optionally, one or more organic solvents and/or co-solvents. Preferably, the crystallization inhibitor is N-octyl pyrrolidone, and the organic solvent, if present, preferably comprises diethylene glycol monoethyl ether. The ectoparasiticidal formulation surprisingly yields a significantly enhanced speed of kill. Methods for manufacturing the formulation, as well as methods for treating animals infested with ectoparasites, are also disclosed.

Abstract: The invention provides an ectoparasiticidal formulation which comprises an ectoparasiticidal agent, preferably the pyrethroid tetramethrin, as the pesticidally-active ingredient, together with a crystallization inhibitor selected from the group consisting of alkyl-substituted pyrrolidones, and optionally, one or more organic solvents and/or co-solvents. Preferably, the crystallization inhibitor is N-octyl pyrrolidone, and the organic solvent, if present, preferably comprises diethylene glycol monoethyl ether. The ectoparasiticidal formulation surprisingly yields a significantly enhanced speed of kill. Methods for manufacturing the formulation, as well as methods for treating animals infested with ectoparasites, are also disclosed.

Abstract: A method of and a composition for treating a parasitic infestation in an animal and/or its environment is provided. The method includes providing an ectoparasitcidal formulation which comprises two or more IGRs, in which the IGRs may be selected from the same IGR class or from different IGR classes (excluding two or more juvenile hormone mimic IGRs selected from S-methoprene, hydroprene and pyriproxyfen) and regardless of whether each IGR is mobile or non-mobile or is capable or incapable of translocation in the environment.

Abstract: Methods and formulations for treating animal ectoparasites, effective against parasites such as fleas and ticks are provided. The methods comprise topically co-administering a non-mobile insect growth regulator, a mobile insect growth regulator, and an adulticide to the animal. Parasiticidal formulations for treating animal ectoparasites are also provided, which can be safe to use and avoids the many common deleterious side effects of conventional topical formulations. The topical formulations comprise a combination of two insect growth regulators and an additional insecticide. The topical formulation can be packaged together or packaged so that active components are stored separately prior to administering the topical insecticide formulation to the animal.

Abstract: The invention provides an ectoparasiticidal formulation which comprises an ectoparasiticidal agent, preferably the pyrethroid tetramethrin, as the pesticidally-active ingredient, together with a crystallization inhibitor selected from the group consisting of alkyl-substituted pyrrolidones, and optionally, one or more organic solvents and/or co-solvents. Preferably, the crystallization inhibitor is N-octyl pyrrolidone, and the organic solvent, if present, preferably comprises diethylene glycol monoethyl ether. The ectoparasiticidal formulation surprisingly yields a significantly enhanced speed of kill. Methods for manufacturing the formulation, as well as methods for treating animals infested with ectoparasites, are also disclosed.

Abstract: The invention provides an ectoparasiticidal formulation which comprises an ectoparasiticidal agent, preferably fipronil, as the pesticidally-active ingredient, together with a crystallization inhibitor selected from the group consisting of alkyl-substituted pyrrolidones, and optionally, one or more organic solvents and/or co-solvents. Preferably, the crystallization inhibitor is N-octyl pyrrolidone, and the organic solvent, if present, preferably comprises diethylene glycol monoethyl ether. The ectoparasiticidal formulation surprisingly yields a significantly enhanced speed of kill. Methods for manufacturing the formulation, as well as methods for treating animals infested with ectoparasites, are also disclosed.